Women's Health Policy

ABORTION IN THE U.S.

KFF infographic explaining who regulates mifepristone, showing four entities and their roles: the U.S. Food and Drug Administration approves and regulates medications for safety and effectiveness; state legislatures pass laws that can restrict or protect access; courts rule on legal cases affecting regulation; and Congress can pass federal legislation influencing regulation.

Louisiana v. FDA: Access to Mifepristone Back at the Supreme Court

Louisiana sued the FDA in October 2025, claiming the FDA’s 2023 regulatory change eliminating the requirement that mifepristone be dispensed in-person—allowing it to be mailed or dispensed at retail pharmacies—harm the state's ability to enforce its abortion ban. This brief reviews the Louisiana v. FDA case now before the Supreme Court, and provides an overview of the other pending litigation involving mifepristone, as well as the mounting tension between states seeking to protect abortion and those banning the provision of abortion.

CONTRACEPTIve care IN THE U.S.

New and noteworthy

Over-the-Counter Oral Contraceptive Pills

In July 2023, the FDA approved Opill, the first daily oral contraceptive pill to become available over the counter (OTC) without a doctor’s prescription. This issue brief provides an overview of OTC oral contraceptives and laws and policies related to insurance coverage.

featured

A promotional image for the the KFF Health Policy 101 Issues in Women’s Health chapter

Health Policy Issues in Women’s Health

Examine the core health coverage and access issues —shaped by federal and state policies—that affect women’s health today, including health coverage and costs, reproductive health services, maternal health, mental health, and intimate partner violence.

State Profiles for Women’s Health

Explore the latest national and state-specific data and policies on women’s health. Topics include health status, insurance and Medicaid coverage, use of preventive services, sexual health, maternal and infant health, and abortion policies. Many indicators provide state-level information for women of different racial and ethnic groups.

The essentials
  • Women’s Health Insurance Coverage

    This factsheet reviews major sources of coverage for women residing in the U.S., discusses the ACA's impact on coverage, and the coverage challenges that many women continue to face.
  • Medicaid Coverage for Women

    This data note presents key data points describing the current state of the Medicaid program as it affects women, including eligibility, reproductive health, chronic conditions, and more.
  • Dobbs: What are the Implications for Racial Disparities?

    This analysis examines the implications of the Dobbs decision and state restrictions on abortion coverage for racial disparities in access to care and health outcomes.
  • State Health Facts: Women's Health Indicators

    Information on women’s health status, utilization of services, health insurance coverage, family planning and childbirth, and abortion statistics and policies.
  • Key Facts on Abortion in the United States

    This report answers some key questions about abortion in the United States and presents data collected before the overturn of Roe v. Wade.

Subscribe to KFF Emails

Choose which emails are best for you.
Sign up here

Filter

361 - 370 of 870 Results

  • Is There a Common Ground? Affiliations Between Catholic and Non-Catholic Health Care Providers and

    Other Post

    3. The Affiliation Process and the Role of Reproductive Health Services in the case studies The four case studies conducted for this project provide insight into the affiliation process between Catholic and non-Catholic health care providers and the role of reproductive health services in the process. The four successfully negotiated affiliations studied included an acquisition, a merger, a consolidation, and a 50/50 joint venture. (See Figure 1 for a summary of the contextual, organizational, and…

  • Emergency Contraception Resources

    Other Post

    Fact Sheet The fact sheet below includes information on EC methods, safety and side effects, and access issues. The fact sheet also provides information women's knowledge and use as well as health care provider attitudes and practices. Emergency Contraception Fact Sheet Survey The survey snapshot and toplines/survey below from the Kaiser Family Foundation's 2001 National Survey of Women's Health Care Providers on Reproductive Health is a national random-sample survey of 790 physicians, including 595 obstetrician…

  • Survey on Women’s Health in the U.S.

    Report

    New Survey on Women's Health in the U.S. A new national survey by the Kaiser Family Foundation finds most women report generally positive experiences with the health care system, but a sizable share faced problems. A significant minority of nonelderly women reported delaying or going without care in the past year or not filling a prescription due to costs. Women are more likely than men both to face these problems and express concerns about the…

  • Emergency Contraception: From Prescription to Over-the-Counter

    Other Post

    This issue update provides information on the process of making emergency contraception available without a prescription. It includes sections on how a drug becomes availible without a prescription;, the over-the counter-debate; implications for cost and use; and safety and efficacy. Issue Update

  • Promoting Access to Prenatal Care: Lessons from the California Experience (Issue Brief)

    Issue Brief

    Improving access to prenatal care has been a public policy priority in the United States for the past 15 years. This issue brief, prepared for the Kaiser Family Foundation by Paula Braveman, M.D. of the University of California, San Francisco and others, examines the impact of the Medicaid pregnancy-related expansions and reforms in California during the late 1980s and 1990s on the use of prenatal care.

  • Emergency Contraceptive Pills

    Fact Sheet

    - Fact Sheet This fact sheet is an update on emergency contraception (EC). It includes information on EC methods, safety and side effects, and access issues. The fact sheet also provides information women's knowledge and use as well as health care provider attitudes and practices. Fact Sheet (.pdf)

  • agendaFIJune13.doc-20000613a-agendaFIJune13-doc

    Other Post

    If the FDA Approves Mifepristone . . . What Happens Next? Will Doctors Provide It? Do Women Want It?And, What Effect Will It Have on Abortion Politics? class=normal>Tuesday, June 13, 20009:30am - 11:30amBroadway Millennium Hotel, Rooms 304/30544th and Broadway, New York City 9:30 am Registration9:50 am Welcome/Introductions10:00 am News from the Frontlines: The Latest on Mifepristone What's Happening with the Food and Drug Administration?Sandra Arnold, Vice President for Corporate Affairs at the Population Council, will…

  • Racial and Ethnic Disparities in Women’s Health Coverage and Access to Care

    Issue Brief

    Using data from the 2001 Kaiser Women’s Health Survey, a nationally representative survey of nearly 4,000 women between the ages of 18 to 64, this issue brief explores racial and ethnic disparities in health care among women. It provides new information on the differences in health status, health insurance coverage, and selected measures of access to care across three racial/ethnic groups of women: African American, Latina, and white. Issue Brief (.pdf)

  • Women’s Health Policy: Are the Times Really A-Changing? – Editorial

    Other Post

    Women's Health Policy: Are the Times Really A-Changing? - Editorial This editorial describes the current state of key women's health policy issues, including reproductive health, long-term care, and Medicaid, and assesses how policymakers might address these issues in the future. The piece was written by Kaiser Vice President and Director of Women's Health Policy, Alina Salganicoff, and was published in the journal Women's Health Issues. Editorial (.pdf)